$16.11
0.805.23%
最終更新: Apr 22, 1:09 PM
Benzinga
Benzinga
Benzinga
水曜日, 4 22
Benzinga
© 2026 Benzinga | All Rights Reserved
最新の Intellia Therapeutics インサイダー取引活動を追跡します。Intellia Therapeutics 株の最近の購入、売却、市場への影響について最新情報を入手してください。
インサイダー取引とは、役員、取締役、従業員などの企業内部関係者が自社の株式の取引を行う行為です。インサイダーの売買取引は、会社の将来の業績に対する彼らの信頼を知る貴重な洞察を提供します。
内部関係者らは、過去30日間に売買はなかったと報告している。
過去90日間にインサイダーによる売買はありませんでした。
| Mar 03, 2026 | James Basta | EVP, GENERAL COUNSEL | 44.87K | $13.78 | -$16.69K | GRANT | 40.09% | 156.79K | Mar 01 - Mar 02 | View |
| Mar 03, 2026 | Eliana Clark | EVP, CHIEF TECHNICAL OFFICER | 6.75K | $13.78 | -$8.36K | GRANT | 7.74% | 93.86K | Mar 01 - Mar 02 | View |
| Jan 07, 2026 | JOHN LEONARD | PRESIDENT AND CEO | -34.15K | $9.21 | -$314.48K | SELL | -3.09% | 1.07M | Jan 05 | View |
| Jan 07, 2026 | Birgit Schultes | EVP, CHIEF SCIENTIFIC OFFICER | -8.51K | $9.21 | -$78.36K | SELL | -7.95% | 98.53K | Jan 05 | View |
| Jan 07, 2026 | James Basta | EVP, GENERAL COUNSEL | -10.40K | $9.21 | -$95.76K | SELL | -9.29% | 101.53K | Jan 05 | View |
| Jan 07, 2026 | Fred Cohen | — | 150.00K | $9.35 | $1.40M | BUY | 261.08% | 207.45K | Jan 05 | View |
| Jan 07, 2026 | David Lebwohl | EVP, CHIEF MEDICAL OFFICER | -11.90K | $9.21 | -$109.63K | SELL | -8.94% | 121.25K | Jan 05 | View |
| Jan 07, 2026 | Eliana Clark | EVP, CHIEF TECHNICAL OFFICER | -9.52K | $9.21 | -$87.63K | SELL | -9.85% | 87.12K | Jan 05 | View |
| Jan 07, 2026 | Edward Dulac III | EVP, CHIEF FINANCIAL OFFICER | -6.38K | $9.21 | -$58.75K | SELL | -6.01% | 99.68K | Jan 05 | View |
| Jan 07, 2026 | Michael Dube | VP, CHIEF ACCOUNTING OFFICER | -2.99K | $9.21 | -$27.53K | SELL | -5.41% | 52.28K | Jan 05 | View |
| Dec 12, 2025 | JOHN LEONARD | PRESIDENT AND CEO | -29.63K | $8.16 | -$436.72K | SELL | -2.61% | 1.11M | Dec 11 - Dec 12 | View |
| Oct 03, 2025 | Birgit Schultes | EVP, CHIEF SCIENTIFIC OFFICER | -31.00 | $17.38 | -$538.78 | SELL | -0.03% | 105.18K | Oct 01 | View |
| Oct 03, 2025 | Michael Dube | VP, CHIEF ACCOUNTING OFFICER | -1.87K | $17.38 | -$32.52K | SELL | -3.27% | 55.27K | Oct 01 | View |
| Aug 22, 2025 | WILLIAM CHASE | — | 100.00K | $10.03 | $1.00M | BUY | 288.24% | 134.69K | Aug 20 | View |
| Jul 25, 2025 | Edward Dulac III | EVP, CHIEF FINANCIAL OFFICER | -7.46K | $14.02 | -$104.62K | SELL | -6.57% | 106.06K | Jul 23 | View |
| Jul 03, 2025 | Eliana Clark | EVP, CHIEF TECHNICAL OFFICER | -1.02K | $9.82 | -$10.04K | SELL | -1.06% | 95.37K | Jul 01 | View |
| Jul 03, 2025 | Michael Dube | VP, CHIEF ACCOUNTING OFFICER | -2.50K | $9.95 | -$24.90K | SELL | -4.20% | 57.14K | Jul 02 | View |
| Jul 02, 2025 | JESSE GOODMAN | — | -3.09K | $9.40 | -$29.07K | SELL | -11.27% | 24.36K | Jun 30 - Jul 01 | View |
| May 01, 2025 | Muna Bhanji | — | -265.00 | $8.50 | -$2.25K | SELL | -1.36% | 19.20K | Apr 29 | View |
| Mar 04, 2025 | Eliana Clark | EVP, CHIEF TECHNICAL OFFICER | 31.32K | $8.99 | -$6.10K | GRANT | 48.90% | 95.37K | Mar 01 - Mar 04 | View |
| Mar 04, 2025 | James Basta | EVP, GENERAL COUNSEL | 37.43K | $8.99 | -$23.12K | GRANT | 50.24% | 111.92K | Mar 01 - Mar 04 | View |
| Jan 31, 2025 | Muna Bhanji | — | -265.00 | $9.97 | -$2.64K | SELL | -1.34% | 19.47K | Jan 29 | View |
| Jan 07, 2025 | Michael Dube | VP, CHIEF ACCOUNTING OFFICER | -1.37K | $12.18 | -$16.71K | SELL | -2.92% | 45.64K | Jan 03 | View |
| Jan 07, 2025 | James Basta | EVP, GENERAL COUNSEL | -7.07K | $12.18 | -$86.16K | SELL | -8.67% | 74.50K | Jan 03 | View |
| Jan 07, 2025 | David Lebwohl | EVP, CHIEF MEDICAL OFFICER | -9.56K | $12.18 | -$116.40K | SELL | -9.83% | 87.67K | Jan 03 | View |
| Jan 07, 2025 | Derek Hicks | EVP, CHIEF BUSINESS OFFICER | -6.50K | $12.18 | -$79.19K | SELL | -9.80% | 59.88K | Jan 03 | View |
| Jan 07, 2025 | JOHN LEONARD | PRESIDENT AND CEO | -26.81K | $12.18 | -$326.51K | SELL | -2.61% | 999.53K | Jan 03 | View |
| Jan 07, 2025 | Laura SeppLorenzino | EVP, CHIEF SCIENTIFIC OFFICER | -8.97K | $12.18 | -$109.21K | SELL | -10.38% | 77.39K | Jan 03 | View |
| Jan 06, 2025 | Eliana Clark | EVP, CHIEF TECHNICAL OFFICER | -7.98K | $12.17 | -$97.09K | SELL | -11.08% | 64.05K | Jan 02 - Jan 03 | View |
| Oct 04, 2024 | Michael Dube | VP, CHIEF ACCOUNTING OFFICER | -2.01K | $19.01 | -$38.25K | SELL | -4.10% | 47.01K | Oct 02 | View |
| Jul 03, 2024 | Eliana Clark | EVP, CHIEF TECHNICAL OFFICER | -405.00 | $22.93 | -$9.29K | SELL | -0.56% | 71.47K | Jul 01 | View |
| Jun 20, 2024 | Frank Verwiel | — | -1.50K | $25.00 | -$37.63K | SELL | -7.74% | 17.95K | Jun 17 | View |
| Mar 05, 2024 | James Basta | EVP, GENERAL COUNSEL | 30.10K | $32.99 | -$75.78K | GRANT | 58.47% | 81.57K | Mar 01 - Mar 04 | View |
| Mar 05, 2024 | Eliana Clark | EVP, CHIEF TECHNICAL OFFICER | 30.63K | $32.99 | -$19.96K | GRANT | 74.98% | 71.47K | Mar 01 - Mar 04 | View |
| Jan 10, 2024 | Laura SeppLorenzino | EVP, CHIEF SCIENTIFIC OFFICER | -2.27K | $28.87 | -$65.68K | SELL | -4.92% | 43.93K | Jan 08 | View |
| Jan 05, 2024 | JOHN LEONARD | PRESIDENT AND CEO | -19.22K | $29.46 | -$566.31K | SELL | -2.08% | 904.90K | Jan 03 | View |
| Jan 05, 2024 | David Lebwohl | EVP, CHIEF MEDICAL OFFICER | -5.84K | $29.46 | -$172.13K | SELL | -9.70% | 54.37K | Jan 03 | View |
| Jan 05, 2024 | Laura SeppLorenzino | EVP, CHIEF SCIENTIFIC OFFICER | -5.53K | $29.46 | -$162.97K | SELL | -10.69% | 46.20K | Jan 03 | View |
| Jan 05, 2024 | Glenn Goddard | EVP, CHIEF FINANCIAL OFFICER | -5.37K | $29.46 | -$158.05K | SELL | -11.68% | 40.59K | Jan 03 | View |
| Jan 05, 2024 | Derek Hicks | EVP, CHIEF BUSINESS OFFICER | -3.88K | $29.46 | -$114.22K | SELL | -9.49% | 36.99K | Jan 03 | View |
| Jan 05, 2024 | James Basta | EVP, GENERAL COUNSEL | -3.81K | $29.46 | -$112.10K | SELL | -6.88% | 51.47K | Jan 03 | View |
| Jan 05, 2024 | Eliana Clark | EVP, CHIEF TECHNICAL OFFICER | -4.61K | $29.50 | -$135.95K | SELL | -10.14% | 40.84K | Jan 03 | View |
| Nov 02, 2023 | Muna Bhanji | DIRECTOR | -265.00 | $23.90 | -$6.33K | SELL | -2.16% | 12.00K | Oct 31 | View |
| Aug 02, 2023 | Muna Bhanji | DIRECTOR | -265.00 | $42.33 | -$11.22K | SELL | -2.12% | 12.26K | Jul 31 | View |
| Jul 10, 2023 | Muna Bhanji | DIRECTOR | -1.87K | $39.30 | -$73.37K | SELL | -12.97% | 12.53K | Jul 06 | View |
| Jul 06, 2023 | Eliana Clark | EVP, CHIEF TECHNICAL OFFICER | -360.00 | $40.51 | -$14.58K | SELL | -0.79% | 45.15K | Jul 03 | View |
| Jun 22, 2023 | Eliana Clark | EVP, CHIEF TECHNICAL OFFICER | 0.00 | $28.63 | -$163.65K | SELL-OPTIONS | 0.00% | 45.15K | Jun 20 | View |
| Mar 03, 2023 | James Basta | EVP, GENERAL COUNSEL | 35.72K | $43.88 | -$47.74K | GRANT | 182.63% | 55.28K | Mar 01 - Mar 02 | View |
| Jan 06, 2023 | Laura SeppLorenzino | EVP, CHIEF SCIENTIFIC OFFICER | -4.84K | $37.82 | -$182.98K | SELL | -21.53% | 17.63K | Jan 04 - Jan 05 | View |
| Jan 06, 2023 | JOHN LEONARD | PRESIDENT AND CEO | -6.67K | $37.21 | -$248.30K | SELL | -0.80% | 825.24K | Jan 04 | View |
| Jan 06, 2023 | Derek Hicks | EVP, CHIEF BUSINESS OFFICER | -1.81K | $37.21 | -$67.42K | SELL | -9.48% | 17.31K | Jan 04 | View |
| Jan 06, 2023 | David Lebwohl | EVP, CHIEF MEDICAL OFFICER | -2.57K | $37.21 | -$95.78K | SELL | -9.11% | 25.69K | Jan 04 | View |
| Jan 06, 2023 | Glenn Goddard | EVP, CHIEF FINANCIAL OFFICER | -2.43K | $37.21 | -$90.31K | SELL | -13.61% | 15.40K | Jan 04 | View |
| Jan 06, 2023 | Eliana Clark | EVP, CHIEF TECHNICAL OFFICER | -2.03K | $37.65 | -$76.36K | SELL | -12.29% | 14.47K | Jul 01 - Jan 04 | View |
| Jan 06, 2023 | James Basta | EVP, GENERAL COUNSEL | -1.14K | $37.21 | -$42.34K | SELL | -5.50% | 19.56K | Jan 04 | View |
| Mar 04, 2022 | JOHN LEONARD | PRESIDENT AND CEO | 46.34K | $112.25 | -$279.85K | SELL-OPTIONS | 5.96% | 824.07K | Jan 01 - Mar 01 | View |
| Mar 03, 2022 | Laura SeppLorenzino | EVP, CHIEF SCIENTIFIC OFFICER | 16.17K | $112.25 | -$128.86K | SELL-OPTIONS | 656.44% | 18.63K | Jan 01 - Mar 01 | View |
| Mar 03, 2022 | David Lebwohl | EVP, CHIEF MEDICAL OFFICER | 15.95K | $112.24 | -$117.96K | SELL-OPTIONS | 181.56% | 24.74K | Jan 01 - Mar 01 | View |
| Mar 03, 2022 | Glenn Goddard | EVP, CHIEF FINANCIAL OFFICER | 14.77K | $112.24 | -$113.70K | SELL-OPTIONS | ∞ | 14.77K | Jan 01 - Mar 01 | View |
| Nov 09, 2021 | David Lebwohl | EVP, CHIEF MEDICAL OFFICER | 0.00 | $72.67 | -$288.25K | SELL-OPTIONS | 0.00% | 8.71K | Nov 05 | View |
| Oct 15, 2021 | David Lebwohl | EVP, CHIEF MEDICAL OFFICER | 0.00 | $70.53 | -$277.96K | SELL-OPTIONS | 0.00% | 8.71K | Oct 14 | View |
| Oct 13, 2021 | John Crowley | DIRECTOR | 0.00 | $69.19 | -$251.80K | SELL-OPTIONS | 0.00% | 2.09K | Oct 11 | View |
| Oct 07, 2021 | John Crowley | DIRECTOR | 0.00 | $74.68 | -$1.12M | SELL-OPTIONS | 0.00% | 2.09K | Oct 05 | View |
| Sep 23, 2021 | David Lebwohl | EVP, CHIEF MEDICAL OFFICER | 0.00 | $81.22 | -$329.26K | SELL-OPTIONS | 0.00% | 791.00 | Sep 21 | View |
| Sep 09, 2021 | Glenn Goddard | EVP, CHIEF FINANCIAL OFFICER | 0.00 | $97.35 | -$576.41K | SELL-OPTIONS | 0.00% | 0.00 | Sep 07 | View |
| Sep 01, 2021 | JOHN LEONARD | PRESIDENT AND CEO | 0.00 | $88.95 | -$17.45M | SELL-OPTIONS | 0.00% | 777.72K | Aug 30 - Sep 01 | View |
| Sep 01, 2021 | Laura SeppLorenzino | EVP, CHIEF SCIENTIFIC OFFICER | 0.00 | $84.42 | -$13.66M | SELL-OPTIONS | 0.00% | 2.39K | Aug 30 | View |
| Sep 01, 2021 | David Lebwohl | EVP, CHIEF MEDICAL OFFICER | 0.00 | $85.33 | -$349.01K | SELL-OPTIONS | 0.00% | 791.00 | Aug 30 | View |
| Sep 01, 2021 | Glenn Goddard | EVP, CHIEF FINANCIAL OFFICER | 0.00 | $89.22 | -$4.21M | SELL-OPTIONS | 0.00% | 0.00 | Aug 30 - Aug 31 | View |
| Aug 25, 2021 | JOHN LEONARD | PRESIDENT AND CEO | 0.00 | $82.71 | -$3.76M | SELL-OPTIONS | 0.00% | 777.72K | Aug 23 | View |
| Aug 20, 2021 | JOHN LEONARD | PRESIDENT AND CEO | 0.00 | $82.34 | -$3.13M | SELL-OPTIONS | 0.00% | 777.72K | Aug 19 | View |
| Aug 11, 2021 | David Lebwohl | EVP, CHIEF MEDICAL OFFICER | 0.00 | $88.34 | -$363.43K | SELL-OPTIONS | 0.00% | 791.00 | Aug 09 | View |
| Aug 06, 2021 | Laura SeppLorenzino | EVP, CHIEF SCIENTIFIC OFFICER | 0.00 | $75.82 | -$3.25M | SELL-OPTIONS | 0.00% | 2.39K | Aug 04 | View |
| Aug 06, 2021 | Glenn Goddard | EVP, CHIEF FINANCIAL OFFICER | 0.00 | $85.16 | -$2.64M | SELL-OPTIONS | 0.00% | 0.00 | Aug 05 | View |
| Jun 29, 2021 | FRANCOIS JEAN FORMELA | DIRECTOR | -553.38K | $132.73 | -$73.45M | SELL | -98.22% | 10.00K | Jun 28 | View |
| Jun 15, 2021 | FRANCOIS JEAN FORMELA | DIRECTOR | -201.72K | $87.04 | -$17.56M | SELL | -26.37% | 563.38K | Jun 11 - Jun 14 | View |
| Apr 30, 2021 | FRANCOIS JEAN FORMELA | DIRECTOR | -4.51K | $85.43 | -$385.55K | SELL | -0.59% | 765.10K | Apr 29 | View |
| Apr 28, 2021 | FRANCOIS JEAN FORMELA | DIRECTOR | -342.96K | $85.96 | -$29.48M | SELL | -30.83% | 769.61K | Apr 26 - Apr 28 | View |
| Apr 07, 2021 | FRANCOIS JEAN FORMELA | DIRECTOR | -800.00 | $84.98 | -$67.98K | SELL | -0.07% | 1.11M | Apr 05 | View |
| Apr 06, 2021 | CAROLINE DORSA | DIRECTOR | 0.00 | $44.29 | -$568.40K | SELL-OPTIONS | 0.00% | 5.41K | Apr 05 | View |
| Apr 02, 2021 | JOHN LEONARD | PRESIDENT AND CEO | 32.83K | $48.89 | -$2.19M | SELL-OPTIONS | 4.57% | 751.78K | Apr 01 | View |
| Apr 02, 2021 | Jose Rivera | EVP, GENERAL COUNSEL | 46.55K | $47.49 | -$2.95M | SELL-OPTIONS | 12.31% | 424.60K | Apr 01 | View |
| Mar 01, 2021 | FRANCOIS JEAN FORMELA | DIRECTOR | -501.94K | $60.29 | -$30.26M | SELL | -31.07% | 1.11M | Feb 26 | View |
| Feb 09, 2021 | Jose Rivera | EVP, GENERAL COUNSEL | 9.51K | $46.65 | -$477.48K | SELL-OPTIONS | 2.57% | 380.13K | Feb 09 | View |
| Feb 09, 2021 | JOHN LEONARD | PRESIDENT AND CEO | 45.73K | $40.62 | -$2.73M | SELL-OPTIONS | 6.79% | 718.95K | Feb 05 - Feb 09 | View |
| Feb 03, 2021 | JOHN LEONARD | PRESIDENT AND CEO | 139.31K | $41.21 | -$7.15M | SELL-OPTIONS | 26.09% | 673.22K | Feb 01 - Feb 03 | View |
| Feb 03, 2021 | Jose Rivera | EVP, GENERAL COUNSEL | 54.34K | $36.84 | -$2.44M | SELL-OPTIONS | 17.18% | 370.62K | Feb 01 | View |
| Jan 05, 2021 | JOHN LEONARD | PRESIDENT AND CEO | 8.14K | $55.86 | -$348.51K | SELL-OPTIONS | 1.55% | 533.90K | Dec 31 - Jan 05 | View |
| Jan 05, 2021 | ANDREW SCHIERMEIER | EVP, CHIEF OPERATING OFFICER | 3.42K | $55.86 | -$76.92K | SELL-OPTIONS | 25.79% | 16.66K | Dec 31 - Jan 05 | View |
| Jan 05, 2021 | Jose Rivera | EVP, GENERAL COUNSEL | 2.71K | $55.86 | -$116.08K | SELL-OPTIONS | 0.87% | 314.20K | Dec 31 - Jan 05 | View |
| Dec 18, 2020 | PERRY KARSEN | — | 0.00 | $36.00 | -$3.12M | OPTION EXERCISE | 0.00% | 5.00K | Dec 17 | View |
| Dec 03, 2020 | Jose Rivera | — | 1.64K | $26.04 | -$59.13K | OPTION EXERCISE | 0.53% | 310.92K | Dec 01 | View |
| Nov 27, 2020 | JOHN LEONARD | — | 0.00 | $27.37 | -$783.90K | OPTION EXERCISE | 0.00% | 525.77K | Nov 27 | View |
| Nov 25, 2020 | JOHN LEONARD | — | 0.00 | $21.41 | -$1.46M | OPTION EXERCISE | 0.00% | 525.77K | Nov 25 | View |
| Nov 18, 2020 | JOHN LEONARD | — | 0.00 | $24.29 | -$388.40K | OPTION EXERCISE | 0.00% | 525.77K | Nov 16 | View |
| Nov 18, 2020 | Jose Rivera | — | 4.76K | $21.30 | -$134.47K | OPTION EXERCISE | 1.56% | 309.28K | Nov 16 - Nov 18 | View |
| Nov 06, 2020 | Jose Rivera | — | 1.64K | $20.94 | -$24.79K | OPTION EXERCISE | 0.54% | 304.52K | Nov 04 | View |
| Nov 06, 2020 | JOHN LEONARD | — | 0.00 | $16.41 | -$958.50K | OPTION EXERCISE | 0.00% | 525.77K | Nov 04 | View |
| Oct 16, 2020 | Jose Rivera | — | 4.38K | $15.52 | -$67.58K | OPTION EXERCISE | 1.47% | 302.89K | Oct 15 | View |
| Oct 09, 2020 | JOHN LEONARD | — | 0.00 | $14.33 | -$75.00K | OPTION EXERCISE | 0.00% | 525.77K | Oct 07 | View |
| Sep 17, 2020 | Jose Rivera | — | 4.38K | $13.93 | -$49.84K | OPTION EXERCISE | 1.49% | 298.50K | Sep 15 | View |
| Sep 03, 2020 | JOHN LEONARD | — | 0.00 | $14.33 | -$75.00K | OPTION EXERCISE | 0.00% | 525.77K | Sep 01 | View |
| Aug 20, 2020 | Jose Rivera | EVP, GENERAL COUNSEL | 4.38K | $13.91 | -$49.62K | SELL-OPTIONS | 1.51% | 294.12K | Aug 18 | View |
| Aug 07, 2020 | JOHN LEONARD | — | 0.00 | $14.33 | -$75.00K | OPTION EXERCISE | 0.00% | 525.77K | Aug 06 | View |
| Jul 17, 2020 | Jose Rivera | — | 4.38K | $14.77 | -$59.16K | OPTION EXERCISE | 1.54% | 289.73K | Jul 15 | View |
| Jul 02, 2020 | JOHN LEONARD | — | 0.00 | $14.33 | -$75.00K | OPTION EXERCISE | 0.00% | 525.77K | Jul 01 | View |
| Jun 18, 2020 | Jose Rivera | — | 4.38K | $13.91 | -$49.62K | OPTION EXERCISE | 1.57% | 284.49K | Jun 16 | View |
| Jun 05, 2020 | JOHN LEONARD | — | 0.00 | $14.33 | -$75.00K | OPTION EXERCISE | 0.00% | 525.77K | Jun 03 | View |
| May 28, 2020 | Jose Rivera | — | 4.38K | $14.02 | -$50.79K | OPTION EXERCISE | 1.59% | 280.11K | May 26 | View |
| Mar 12, 2019 | ANDREW SCHIERMEIER | EVP, DEV AND CORP STRATEGY | 7.50K | $15.72 | $117.88K | BUY | 86.77% | 16.14K | Mar 06 | View |
| Jul 18, 2018 | FRANCOIS JEAN FORMELA | DIRECTOR | -6.69K | $31.17 | -$208.40K | SELL | -0.41% | 1.62M | Jul 16 | View |
| Jun 20, 2018 | FRANCOIS JEAN FORMELA | DIRECTOR | -6.69K | $27.96 | -$186.91K | SELL | -0.36% | 1.84M | Jun 19 | View |
| May 17, 2018 | FRANCOIS JEAN FORMELA | DIRECTOR | -6.69K | $25.04 | -$167.39K | SELL | -0.32% | 2.06M | May 16 | View |
| May 15, 2018 | JOHN LEONARD | PRESIDENT AND CEO | -8.40K | $24.00 | -$201.60K | SELL | -12.57% | 58.41K | May 14 | View |
| Mar 22, 2018 | FRANCOIS JEAN FORMELA | DIRECTOR | -39.24K | $23.87 | -$936.74K | SELL | -1.69% | 2.28M | Mar 20 | View |
| Jan 30, 2018 | Caribou Biosciences Inc | — | -550.64K | $26.78 | -$14.75M | SELL | -12.12% | 3.99M | Jan 29 | View |
| Dec 14, 2017 | Novartis Institutes for BioMedical Research IncAG NOVARTIS | 10% OWNER | -1.52M | $18.30 | -$27.87M | SELL | -26.94% | 4.13M | Dec 12 | View |
| Dec 08, 2017 | Nessan Bermingham | PRESIDENT & CEO | -336.78K | $20.78 | -$7.00M | SELL | -42.36% | 458.25K | Dec 06 - Dec 08 | View |
| Sep 13, 2017 | Caribou Biosciences Inc | — | -1.05M | $0.00 | $0.00 | SELL | -18.75% | 4.54M | Sep 13 | View |
| Jul 11, 2017 | FRANCOIS JEAN FORMELA | DIRECTOR | -150.00K | $16.24 | -$2.44M | SELL | -4.02% | 3.58M | Jul 07 - Jul 11 | View |
| Jul 11, 2017 | Atlas Venture Fund IX LPAtlas Venture Associates IX LPAtlas Venture Associates IX LLC | 10% OWNER | -150.00K | $16.24 | -$2.44M | SELL | -4.02% | 3.58M | Jul 07 - Jul 11 | View |
| Mar 13, 2017 | Atlas Venture Associates IX LPAtlas Venture Associates IX LLC | 10% OWNER | -21.13K | $13.91 | -$293.84K | SELL | -0.56% | 3.73M | Mar 09 - Mar 10 | View |
| Mar 13, 2017 | FRANCOIS JEAN FORMELA | DIRECTOR | -21.13K | $13.91 | -$293.84K | SELL | -0.56% | 3.73M | Mar 09 - Mar 10 | View |
| May 13, 2016 | ORBIMED ADVISORS LLCOrbiMed Capital GP V LLCOrbiMed Global Healthcare GP LLCSamuel D Isaly | DIRECTOR | 2.66M | $18.00 | $4.50M | BUY | ∞ | 2.66M | May 11 | View |
| May 13, 2016 | Temasek Holdings Private LtdFullerton Management Pte LtdTemasek Life Sciences Private LtdTLS Beta Pte Ltd | 10% OWNER | 790.53K | $18.00 | $5.40M | BUY | ∞ | 790.53K | May 11 | View |
| May 11, 2016 | Novartis Institutes for BioMedical Research IncAG NOVARTIS | 10% OWNER | 5.57M | $18.00 | $5.00M | BUY | ∞ | 5.57M | May 11 | View |
| May 11, 2016 | CARL GORDON | DIRECTOR | 2.66M | $18.00 | $4.50M | BUY | ∞ | 2.66M | May 11 | View |
| May 11, 2016 | BAKER BROS ADVISORS LPFELIX BAKERJULIAN BAKERBaker Bros Advisors GP LLC | — | 1.06M | $18.00 | $3.60M | BUY | ∞ | 976.21K | May 11 | View |